المؤلفون: Stefan HE Kaufmann (11283618), Hazel M Dockrell (10414616), Nick Drager (11283621), Mei Mei Ho (3595133), Helen McShane (80704), Olivier Neyrolles (72204), Tom HM Ottenhoff (10577000), Brij Patel (11283624), Danielle Roordink (11283627), François Spertini (27385), Steffen Stenger (111004), Jelle Thole (269877), Frank AW Verreck (11283630), Ann Williams (585185), TBVAC2020 Consortium (11283633), Katalin Wilkinson (3541535), Robert Wilkinson (3529787)

مصطلحات موضوعية: Immunology, Model organisms, Human Biology & Physiology, Infectious Disease, bacille Calmette–Guérin, biomarker, clinical trial, discovery, portfolio management, tuberculosis, vaccination, TBVAC2020 Consortium, Wilkinson, R FC001218, 1107 Immunology, 1108 Medical Microbiology

Relation: https://figshare.com/articles/journal_contribution/TBVAC2020_Advancing_tuberculosis_vaccines_from_discovery_to_clinical_development_/15179736

الاتاحة: https://doi.org/10.25418/crick.15179736.v1